Researchers have been investigating sleep and its own effects on the population for a long period. One of many current focuses is on anti snoring, a sleep disorder characterized by frequent stops in breathing. Consequences of sleep apnea could be serious, including hypertension, stroke and cardiovascular disease, and currently affects over 18 million Americans. Sleep apnea study, therefore, can benefit a significant portion of the population.
The National Sleep Foundation, the American ANTI SNORING Association, and The National Institutes of Health’s (NIH) National Institute of Neurological Disorders and Stroke and the National Focus on Sleep Disorders Research, are a few organizations who conduct sleep apnea studies. These sleep apnea study researchers not merely examine the foundation and the effects of the disorder, but other diseases and disorders which might be affected by anti snoring.
One such anti snoring study may be the National Heart, Lung, and Blood Institute (NHLBI) of NIH’s “Sleep Heart Health Study” (SHHS). NHLBI reported in April of 2000 that middle-aged and older adults with sleep apnea showed a 45 percent greater risk of hypertension–a major risk factor for cardiovascular disease. The sleep apnea study involved a lot more than 6,000 adults aged 40 and over, whose sleep apnea was assessed via in the home polysomnography (PSG). PSG records body activity during sleep, such as eye movement, heart rate, respiratory effort, airflow and blood oxygen levels. The effect: the chance of hypertension increased with the severity of the apnea in every participants, irrespective of age, sex, race, or weight. The risk was evident even at moderate levels of sleep apnea.
A different sleep apnea study, conducted by Jana R. Cooke, MD, of the University of California at NORTH PARK, examined patients with both Alzheimer disease and a sleep-related breathing disorder. This study focused on 48 adults, average age 77.8 years, treating them for the sleep disorder with CPAP, continuous positive airway pressure, the most typical treatment for anti snoring. Results: the patients slept more during the night and slept deeper. Since waking episodes are a problem for Alzheimer’s patients, improving their sleep, improved their quality of life.
A third anti snoring study, performed at the St. 睡眠測試過程 , University of New South Wales in Koragah, Australia, centered on the potency of oral devices to help keep the airway available to relieve anti snoring. The anti snoring study consisted of 4 weeks of treatment with the MAS, and a device (an inactive oral appliance). Anti snoring tests were performed on each patient by the end of every treatment period. Results showed that in 59 men and 14 women of the average age of 48 years, the MAS Therapy improved a variety of symptoms associated with anti snoring. Daytime sleepiness was reduced, as was sleep latency (the time it takes to fall asleep once lights are out.)
These three sleep apnea studies are but a little portion of research projects for anti snoring. NIH’s currently lists over 50 anti snoring studies on the website as “happening” or “looking for subjects.